E. coli in 5 states, May it even be a most cancers remedy?.
Rakuten CEO Mickey Mikitani positive thinks so. The serial entrepreneur entered the world of biotech following a devastating pancreatic most cancers analysis for his father again in 2012. The tragedy spurred him to hunt distinctive options to the most cancers scourge—together with a extremely uncommon strategy known as “photoimmunotherapy.”
“One in every of my associates known as me, who was additionally a pal of my father’s… and stated, by the way in which, my cousin is doing this new undertaking, making an attempt to treatment most cancers with mild,” Mikitani defined throughout a one-on-one interview at our Fortune Brainstorm Well being convention on Wednesday. “I used to be like, this should be a joke. However I used to be determined.”
Mikitani’s father was finally taken by the sickness. However that didn’t cease him from evangelizing this type of most cancers remedy, which includes infusing sufferers with an “antibody-drug conjugate” (i.e., a pairing of an antibody that makes its technique to tumors and a drug that may assault stated tumors), after which activating the tumor-killing course of with the usage of near-infrared mild.
Rakuten Aspyrion already has a number of therapies utilizing this photoimmunotherapy platform in each early- and late-stage medical trials. “I used to be ignorant sufficient to guess on this one,” he says of his unconventional strategy.
Learn on for the day’s information, and have an exquisite weekend.